Latest filing published 24 Nov 2020 for Tango Therapeutics, Inc., €13.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
BCTG Holdings, LLC is a declared insider of Tango Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 8 September 2020 and the latest from 20 November 2020.
Market trades split into 1 purchase (€4.5M) and 2 sales (€25). On balance, insiders were net buyers of €4.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 24 November 2020 came the latest disclosure, an open-market sale for €13 in Tango Therapeutics, Inc. The last purchase on record was published on 10 September 2020, which is 2,234 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations